fda shortage list semaglutide not allowing compounded The FDA has removed semaglutide injection products (GLP-1) from the FDA Declares Shortage of Novo
Description
Both gastroparesis and intestinal blockage, which has also been linked to these GLP-1 drugs, can be fatal if not treated (likely including surgery)
NO DOCTOR-PATIENT RELATIONSHIP HAS BEEN CREATED
Is it safe to break open a Wegovy pen to split the dose
Weekly dosing, predictable absorption, and a well-documented safety history are the main reasons most patients and physicians default to it
